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ABSTRACT
Objective: This article analyzes the efficiency of live vaccines obtained from the strains of Brucella abortus 82 and 75/79-AV and RB-51 in some 
regions of Kazakhstan in 2012-2014 and recommends optimal scheme of their use.
Methods: There were analyzed the effectiveness of the use of live vaccines (manufactured in Russia) obtained from strains of B. abortus 19, 82 
and 75/79-AV in combination with post-vaccination diagnostics of brucellosis in cattle in the farmsteads owned by Vostok-moloko Corporation in 
Eastern Kazakhstan in the period of 2012-2015.
Results: The results of these tests prove that studies of animals 1 month after the vaccination have helped to further identify the animals with hidden 
form of brucellosis provoked by R-vaccine, which explains the favorable outcome of the research.
Conclusion: The above-described scheme of anti-brucellosis activities ensures effective control of the epizootic process of brucellosis by establishing 
“permanent” (continuous) immunity and permanent control of epizooty in brucellosis threatened/unsafe herds.
Keywords: Brucellosis vaccine, Immunization, Efficiency, Anti-brucellosis measures.
INTRODUCTION
Despite all the veterinary efforts on elimination of brucellosis infection 
in Kazakhstan, the epizootic situation with brucellosis remains 
disturbing. It was identified that brucellosis in cattle and small 
ruminants has a significant role among infectious pathology diseases in 
the Republic of Kazakhstan, which significantly reduces the population 
of livestock and negatively affects the national economy [1,2]. Scientific 
and practical experience shows that in the present conditions any anti-
brucellosis efforts for the cattle in unsafe and infection threatened 
areas cannot be effective enough without the use of vaccines [3,4]. 
Vaccination is aimed at the formation of immunity in animals and 
reduction of the risk of spread of the disease. The strategy of mass 
vaccination was common for Kazakhstan until 2006. The cattle was 
vaccinated against brucellosis with the vaccines prepared from a 
strain of Brucella abortus -19 and 82, while the vaccines for the small 
ruminants were prepared from B. melitensis strain Rev-1. From 2006 
to 2012, the anti-brucellosis measures in the country were carried out 
without vaccination, which caused a complicated epizootic situation 
with brucellosis in animals. With all this in mind, it becomes relevant to 
study and review anti-brucellosis activities carried out in the Republic 
of Kazakhstan with the use of vaccination. The resulting data will help 
to make a justified decision about the optimal scheme of using the anti-
brucellosis vaccines.
METHODS
Analysis of anti-epizootic efforts for the cases of brucellosis in livestock 
with use of different vaccines was performed through the collection 
and study of data from veterinary reports of the Committee for 
veterinary control and surveillance under RSE “Republican Veterinary 
Laboratory,” the KZ Ministry of Agriculture and by conducting our own 
epizootic and diagnostic studies of animals on farmsteads in certain 
regions.
Results of research
From 2006 to 2012, the specific animal health-care anti-brucellosis 
actions for the cases of brucellosis in cattle in the country were 
carried out in the form of systematic diagnostic studies and slaughter 
of positively reacting animals. However, veterinary reports data show 
that this method has not provided positive results and achievements in 
improving the brucellosis control has often been followed by periods of 
brucellosis unsafe situation [5].
Given this situation, in 2012, some livestock farms of the republic 
started using vaccine obtained from strain B. abortus 82, 19, 75/79-AV, 
RB 51 as a part of the set of cattle brucellosis control measures.
In the beginning, we have analyzed the effectiveness of the use of live 
vaccines (manufactured in Russia) obtained from strains of B. abortus 
19, 82 and 75/79-AV in combination with post-vaccination diagnostics 
of brucellosis in cattle in the farmsteads owned by Vostok-moloko 
Corporation in Eastern Kazakhstan in the period of 2012-2015.
Young animals of 3-4 months old were immunized with a vaccine 
obtained from the strain 82 (based on epizootological indications, 
it was a vaccine obtained from the strain 19). Heifers that were 
2-3 months before their insemination and then cows with an interval 
of 1 year were reimmunized with a vaccine obtained from the strain 82. 
In situations where the adult breeding livestock, including pregnant 
animals, had no immunity or their immunity was doubtful, the primary 
immunization of animals was carried out with non-abortive vaccine 
obtained from strain 75/79-AV, and subsequently reimmunized with a 
vaccine obtained from strain 82 with an interval of 1 year.
Until September 2012, three other farmsteads owned by the corporation 
(Ukrainka, Donskoye, and Shemonaikha), demonstrated a number of 
their animals that were seropositive for brucellosis. Veterinary health-
care measures in such herds went practically without the use of anti-
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brucellosis vaccines - in Kazakhstan, vaccination against brucellosis 
with live vaccine obtained from strain 82 was officially banned, and 
only in 2011, this ban was partially lifted to allow the use of such 
vaccination for young animals. In September and November 2012, there 
were three comprehensive diagnostic studies of brucellosis in cattle 
blood serum carried out at each of the abovementioned farmsteads. 
The first study with applied set of test methods (AT, complement 
fixation tests [CFT]) showed 2.2% of animals that were epizootically 
dangerous for brucellosis; where 0.8% were revealed through IDT 
with O-PS antigen (indicator of the greatest epizootic hazard); the 
second study showed 1.8% and 0.8% and the third −0.1.3% and 
0.3%, respectively. Such results have led to a decision to use vaccines 
within the reasonable limits, starting December 2012. The first study 
of brucellosis in immunized breeding livestock after vaccination was 
carried out in February - March 2013 and that is 2-3 months following 
the immunization. Such tests allowed provoking hidden forms of 
brucellosis to show up in 3.2% of epizootically dangerous animals 
from the numbers of tested cattle, including 1.3% revealed with the 
use of IDT. There were three more comprehensive studies of brucellosis 
in adult breeding livestock conducted in 2013. These studies have 
revealed 1.7% epizootically dangerous animals from the mean number 
of tested animals, with 0.7% of them diagnosed through IDT with O-PS 
antigen.
There were two other studies conducted in 2014: 0.7% epizootically 
dangerous animals were detected out of the mean number of animals 
tested, with 0.1% of them diagnosed through IDT with O-PS antigen. All 
epizootically dangerous animals were duly isolated from the common 
herd and sent for slaughter.
The presence of positive and tentative reactions during the AT and CFT 
with the S-antigen in low titers indicates the post-vaccination nature of 
these reactions. This is confirmed by the practical absence of positives 
in IDT among the tested animals, which acts as an indicator of the high 
epizootic hazard, as well as by the presence of positives in CFT with 
R-antigen in high titers that acts as an indicator of the vaccinial nature 
of the reactions. Thus, the system of anti-brucellosis measures was 
introduced in brucellosis threatened and unsafe farmsteads of “Vostok-
moloko” Corporation by ensuring permanent immunity in herds of 
cattle using live vaccines obtained from strains 19, 82 and 75/79-AV 
and post-vaccination diagnostics with rational use of their provocative 
properties.
This helped to decrease the number of revealed epizootically dangerous 
animals to few individual cases in certain cattle herds within 2-year 
period.
The live anti-brucellosis vaccine B. abortus obtained from the strain RB 
51 (manufactured in the USA) is registered in the Register of veterinary 
products of Kazakhstan since 2012.
It is prepared from R-forms of Brucella, therefore it does not cause the 
formation of S- antibodies in the immunized organism, so the study of 
vaccinated animals may be carried out at any time after immunization 
and that favorably distinguishes it from other vaccines [6-11].
The vaccine for prevention of brucellosis in cattle is being used in some 
farms of Kazakhstan since 2012.
We have analyzed the effectiveness of using this and other live vaccines 
obtained from strains of B. abortus 82 and 75/79-AV, in some regions of 
Kazakhstan in 2012-2014.
Before the vaccine was applied, the animals were subjected to a single 
serological test (except for animals in North Kazakhstan that were 
tested twice), and the positives were isolated from the herd; the rest 
of the animals were immunized with above-mentioned vaccines in 
accordance with their manuals. Subsequent studies of vaccinated 
animals were carried out in 7-8 months following the immunization. To 
analyze the effectiveness of vaccination in the abovementioned areas, 
we used the data provided by the regional veterinary services and 
diagnostic data from our own research.
Table 1 shows the information about vaccination and diagnostic testing 
of cattle in East Kazakhstan, West Kazakhstan, North Kazakhstan, 
Kostanay, and Karaganda region for the period of 2012-2014.
As it can be seen in Table 1 in the period of 2012-2014, there were 
15428 animals immunized with different anti-brucellosis vaccine in 
Eastern Kazakhstan, where 8491 animals were immunized with the 
vaccine obtained from the strain B. abortus 82, 1715 animals - with 
the vaccine obtained from the strain 75/79-AV and 2552 animals with 
the vaccine obtained from the strain RB 51. The diagnostic serology 
tests conducted in 2013, which is 7-8 months after immunization, has 
revealed the positive results for brucellosis in the 19 animals vaccinated 
with strain 82 based vaccine (infection rate of 1.06%) and in 6 animals 
vaccinated with the strain RB 51 based vaccine (infection rate of 0.7%).
The vaccine that proved to be most effective was the one that was 
obtained from the strain 75/79-AV, since the 3 years long studies of 
1715 animals, vaccinated with this vaccine, and has not revealed any 
positive cases.
In 2014, the vaccine obtained from the strain RB 51 was used in 
Northern Kazakhstan, Western Kazakhstan, Karaganda, and Kostanay 
regions for the prevention of brucellosis in cattle.
The post-vaccination diagnostic studies conducted 7-8 months after the 
animals immunization with the vaccine obtained from the strain RB 51 
have detected the infection with brucellosis in Karaganda region - 3.5%, 
Western Kazakhstan - 7.1%, Kostanay region - 23.0%, which points at 
the lowest immunological efficacy of this vaccine.
To determine the effectiveness of vaccines, we have analyzed each of 
the above-mentioned cases of use of strain RB51 based vaccine for 
prevention of brucellosis in cattle.
Thus, in 2014 in the North-Kazakhstan region, rayon named after M. 
Zhumabaev, in Chistovskoe LLP farmstead a live lyophilized vaccine 
obtained from the strain B. abortus RB-51 (manufactured in the USA) 
was used against cattle brucellosis. Before the vaccine application, the 
rate of infection with brucellosis in this sector was 4.4%.
For the period from 04/30/2014 to 06/17/2014 a total of 235 animals 
were vaccinated, the heifers that were born the same year and prepared 
for tupping. Before vaccination, all the animals have passed through 
diagnostic tests for brucellosis twice. The vaccine was administered 
to negatively reacting animals only and after separating the positively 
reacting animals from the common herd. The tests on these animals 
that were carried out 7 months after immunization all showed negative 
for brucellosis, indicating the absence of brucellosis infection in the 
animals that were subject to potential infection.
Before the vaccine use in the Karaganda region, the level of infection 
with brucellosis in the cattle at Eskene farmstead, Zhanaarka rayon and 
in Kaynar farmstead, Nura rayon was 1.3% and 4.9%, respectively. After 
a single serological test carried out, 1200 animals at these farms were 
immunized in 2014 with the vaccine obtained from the strain RB 51. 
Further studies of these animals 1 year after vaccination showed that 
brucellosis infection was at 3.5%, which also proves the low efficacy of 
the vaccine. There were no registered cases of animal abortions during 
this period.
A complicated epizootic situation with brucellosis in cattle has emerged 
in 2014 in one of the Western Kazakhstan farmsteads where the herd 
infection level has made more than 10%. In August 2014, after the 
serology testing of the entire herd and separation of positively reacting 
animals the animals were vaccinated with the vaccine RB 51 in the 
following proportion: 160 heifers born in 2013 and 205 calves born in 
2014 aged 3-5 months. Subsequent serological study was conducted 
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in March 2015 and revealed the following ratio of positively reacting 
animals: 18 heifers born in 2013, 2 bull calves born in 2014 and 6 
heifers born in 2014. It should be mentioned that 2 of the heifers born 
in 2013 had abortions. A total of 26 animals showed a positive reaction.
Analysis of the cases of use of the vaccine obtained from the strain RB 
51 may lead to a conclusion, that 7 months after immunization, 7.1% 
animals showed positive results for brucellosis, with 2 heifers having 
the abortion. These data demonstrate low immunological efficacy of 
that vaccine.
A study conducted in August 2014 in Tobolsk-1 LLP, Dosovka village, 
Denisovsk rayon of Kostanay region, for brucellosis in 603 animals 
(Rose Bengal test [RBT], CFT, AT), have showed 13 positives while the 
percentage of infection has made 2.1%. It is important to mention that 
the results of tests indicate that no any other actions were made with 
regard to 13 positively reacting animals except for sending them to 
slaughter. Then, 7 months later, in March 2015, the 545 animals on this 
farm were (without approval and notification to the local veterinary 
inspection body) immunized with the anti-brucellosis vaccine obtained 
from B. abortus RB-51 (manufactured in the USA). Moreover, these 
animals were not tested for brucellosis before vaccination. In addition, 
RB 51 vaccine was applied to325 more animals on this farmstead which 
makes total of 870 vaccinated animals.
Later, in June 2015 (3 months after vaccination), during scheduled 
diagnostic serological tests for brucellosis in 926 animals in the 
Dosovka farmstead, 202 cattle had their blood serum showing positive 
results during the conventional serological tests (RBT, CFT, AT), 
including: 112 cows and 90 young animals born in 2015, while the 
percentage of infection has made 21.8%. However, the management of 
Tobolsk LLP took an unreasonable decision not to send the brucellosis 
positive animals to the slaughter, wrongly thinking that these reactions 
are of post-vaccination nature and instead have sent the blood serum of 
112 cows for differential assays in RSE “National Reference Veterinary 
Center,” the KZ Ministry of Agriculture (hereinafter RSE nonresident 
violator compact [NRVC]).
As for the interpretation of test results obtained by RSE NRVC who 
have carried out enzyme-linked immunosorbent assay (ELISA) with 
the test-kit for the detection and differentiation of antibodies to the 
S- and R-forms of the agents of brucellosis, it should be noted that 
93 blood serum samples showed the presence of specific antibodies 
to brucellosis S-shape antigens, which makes these animals referred 
to as the infected with brucellosis and only 5 samples had R-shape 
antibodies. Analysis of the test results for 112 seropositive blood 
serum samples in IDT with O-PS antigen showed that more than 48% 
of the tested animals had positive reaction for brucellosis (Test Report 
#138-15-Ф, dated 07/10/2015).
RESULTS AND DISCUSSION
Thus, the tests result obtained both from ELISA and from IDT with 
O-PS antigen suggest a contagious and not post-vaccination nature of 
demonstrated positive serological reactions.
We believe that in this case, the massive detection of positively reacting 
animals during officially conducted tests for brucellosis, are related 
to the provoking effect of the vaccine obtained from the strain RB-51, 
which is prepared from non-agglutinogenic R-strain of Brucella. Given 
the fact that the animals were not tested for brucellosis before the 
vaccination, the introduced R-vaccine has provoked a “silent” course of 
brucellosis, which has caused massive positive reactions to brucellosis.
Later on, in 2015, for the purpose of a study of the optimal scheme of 
using the vaccine, we conducted on-site tests in Eskene farmstead, 
Zhanaarka rayon of Karaganda region and in Asem farmstead, Akzhaik 
rayon of Western Kazakhstan, by immunizing cattle with the vaccine 
obtained from the strain RB 51. We selected certain quantity of animals 
from each of these two farms from the numbers of breeding livestock 
having the similar epizootic status of the infection with brucellosis.105 
cows in the age of 3-5 years old were tested for brucellosis in July 2015 
in the Eskene farmstead, of Zhanaarka rayon of Karaganda region;4 of 
these cows (3.8%) had positive reactions for brucellosis. 96 cows in the 
age of 3-5 years old, tested in Asem farmstead, Akzhaik rayon of Western 
Kazakhstan, had 3 of them (3.1%) reacting positively before vaccination.
After separation of positive animals from the herd, the rest of the 
animals were immunized with the vaccine obtained from the strain RB 
51 in accordance with its user manuals. A month after immunization 
the animals at both farmsteads were re-examined with the conventional 
tests (AT, CFT, RBT) for brucellosis, and this time each of the herds 
showed 2 animals positively reacting to the brucellosis - these animals 
were also separated from the herd. During the winter period of 
2015-2016, when the cattle is kept in a stall, these animals had no any 
cases of abortion or other manifestations of brucellosis infection.
Routine serological testing of vaccinated animals was carried out 
9 months after immunization (May 2016) with no any observed cases 
of positively reacting animals.
The results of these tests prove that studies of animals 1 month after 
the vaccination have helped to further identify the animals with hidden 
form of brucellosis provoked by R-vaccine, which explains the favorable 
outcome of the research.
Table 1: Data on vaccination and diagnostic studies of cattle in the Republic of Kazakhstan in 2012-2014
Regions, year Type of vaccine Quantity of vaccinated animals Results of serology assays after vaccination
Tested Positives % of infection acquired
Eastern Kazakhstan, 2012-2014 Strain 82 8491 6084
2012 -/-/-/- 534 149 - -
2013 -/-/-/- 2771 1790 19 1.06
2014 -/-/-/- 5186 4145 - -
Eastern Kazakhstan, 2012-2014 Strain 75/79-АВ 1715 840 - -
2012 -/-/-/- 97 97 - -
2013 -/-/-/- 1185 743 - -
2014 -/-/-/- 433 - - -
Eastern Kazakhstan, 2012-2014 Strain RB 51 2552 1561 - -
2012 -/-/-/- 93 54 - -
2013 -/-/-/- 1580 847 6 0.7
2014 -/-/-/- 879 660 13 1.9
North Kazakhstan, 2014 Strain RB 51 235 235 - -
Karaganda region, 2014 Strain RB 51 1200 1200 42 3.5
Western Kazakhstan, 2014 Strain RB 51 365 365 26 7.1
Kostanay region, 2014 Strain RB 51 870 870 202 23.0
Total 15428 11155 308 2.8
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CONCLUSIONS
A positive experience in implementing anti-brucellosis control in 
cattle farmsteads owned by the Vostok-moloko Corporation in Eastern 
Kazakhstan, based on the rational use of live vaccines obtained from 
the strain B. abortus 19, 82 and 75/79-AV, as well as post-vaccination 
diagnostics tools in combination with the common veterinary, 
sanitary, organizational and economic measures, justifies the need of 
applying this scheme in other farms of the Republic of Kazakhstan. 
The above-described scheme of anti-brucellosis activities ensures 
effective control of epizootic process of brucellosis by establishing 
“permanent” (continuous) immunity and permanent control of 
epizooty in brucellosis threatened/unsafe herds [12,13]. As a result, a 
long-term “biological balance” was created and maintained at all levels 
of “animals - organisms” systems, helping to prevent the formation of 
epizootically dangerous options of the pathogen.
A single-time serological testing for brucellosis in cattle before 
immunization with B. abortus vaccine based on the strain RB 51 and 
separation of positively reacting animals does not provide accurate 
detection of all infected animals in the herd. Before use the vaccine, the 
testing of animal for brucellosis should be carried out at least 2 times, 
with a mandatory separation of positive animals from the herd. The use 
of B. abortus vaccine obtained from the strain RB 51 in brucellosis unsafe 
herds did not ensure the formation of the strong immunity. The level of 
infection with brucellosis in herds of animals immunized 7-8 months 
ago was varying from 0.7% to 7.1%. To enhance the effectiveness of 
B. abortus vaccine, obtained from the strain RB 51, it is recommended 
to use it for provoking the latent brucellosis properties.
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